TSP TruSpine Technologies Plc

7 May 2024

TruSpine Technologies plc

("TruSpine" or the "Company")

Directorate Change

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that Laurence Strauss, Chief Executive Officer has resigned as a director of the Company with immediate effect.

Geoff Miller, Chairman commented "I would like to thank Laurence for the work that he has done to progress the Company's development during the time he has been a director of the Company.  The Company has submitted and advanced its FDA application and recently raised further funding providing the Company with a more stable financial footing."

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

Enquiries:

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.